drugset
Drugs / XCEL-MT-OSTEO-BETA
last change Dec 2018 re-read 3 minutes ago

XCEL-MT-OSTEO-BETA

Cell therapy

Developed for
postmenopausal osteoporosis
Investigated by
Blood and Tissue Bank of Catalonia · Fundacion Clinic per a la Recerca Biomédica

Trials 1

today NCT02630836 · Ph 1/2
201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02630836 Dec 2015 → Dec 2017 postmenopausal osteoporosis Blood and Tissue Bank of Catalonia Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as XCEL-MT-OSTEO-BETA ClinicalTrials.gov intervention name — accepted as the source's own label NCT02630836 ↗
Modality Cell therapy “Adult ex-vivo expanded mesenchymal stromal cells from allogeneic bone marrow” NCT02630836 ↗